Albemarle
Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts.
Launch date
Employees
Market cap
€9.3b
Enterprise valuation
€12.9b (Public information from Sep 2024)
Share price
$86.59 ALB
Baton Rouge Louisiana (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 3.1b | 3.3b | 7.3b | 9.6b | 5.6b | 6.4b | 7.3b |
% growth | (13 %) | 6 % | 120 % | 31 % | (42 %) | 14 % | 14 % |
EBITDA | 679m | 153m | 2.9b | 722m | 1.1b | 1.5b | 2.0b |
% EBITDA margin | 22 % | 5 % | 39 % | 8 % | 19 % | 23 % | 27 % |
Profit | 376m | 124m | 2.7b | 1.6b | (830m) | 878m | 2.7b |
% profit margin | 12 % | 4 % | 37 % | 16 % | (15 %) | 14 % | 37 % |
EV / revenue | 5.9x | 8.8x | 3.7x | 2.1x | 2.5x | 2.3x | 2.0x |
EV / EBITDA | 27.3x | 191.4x | 9.5x | 28.0x | 13.1x | 10.2x | 7.4x |
R&D budget | 59.2m | 54.0m | 72.0m | 85.7m | - | - | - |
R&D % of revenue | 2 % | 2 % | 1 % | 1 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | $150m | Grant | |
* | $90.0m | Grant | |
* | $3.6m | Post IPO Equity | |
* | N/A | N/A | Post IPO Convertible |
Total Funding | €218m |
Recent News about Albemarle
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Albemarle Jul 2014
ACQUISITION by Albemarle Sep 2023
exited
ACQUISITION by Albemarle Jun 2023